Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy.
Paskeh MDA, Saebfar H, Mahabady MK, Orouei S, Hushmandi K, Entezari M, Hashemi M, Aref AR, Hamblin MR, Ang HL, Kumar AP, Zarrabi A, Samarghandian S.
Paskeh MDA, et al. Among authors: ang hl.
Life Sci. 2022 Jun 1;298:120463. doi: 10.1016/j.lfs.2022.120463. Epub 2022 Mar 6.
Life Sci. 2022.
PMID: 35259354
Review.